Zydus receives tentative approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
Sirolimus Tablets had annual sales of USD 69 million in the United States (IQVIA MAT Dec. 2022)
USFDA has issued an Establishment Inspection Report (EIR) for Piramal Pharma Limited manufacturing facility located at Lexington (Kentucky, USA) and the inspection has now been successfully closed by the USFDA
This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya
Bosentan Tablets for Oral Suspension had annual sales of USD 16 mn in the United States (IQVIA MAT Dec. 2022)
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
Subscribe To Our Newsletter & Stay Updated